Onyx Bio

Onyx Bio

Pharmaceutical contract manufacturer of sterile injectables

Overview

Onyx Biotec Limited is a pharmaceutical contract manufacturing organization (CDMO) that produces sterile water for injections, dry powder injections, and dry syrups for B2B clients, offering end-to-end development, manufacturing, and regulatory dossier filing. It operates two WHO-GMP certified plants in Solan, Himachal Pradesh, expanded from two lines in 2010 to six by 2020, and opened a second unit in 2023 for dry powder injections and syrups. Its strengths include fully certified facilities with in-house regulatory filing, a client base of over 100 including Sun Pharma, Mankind, Macleods, and Glenmark, and ongoing capacity expansion with a dedicated unit for dry powders. The company plans to use IPO proceeds to upgrade capacity for large-volume parenterals and high-speed packaging, repay debt, and fund growth in global generic manufacturing.

Significant Headcount Growth

About Onyx Bio

Simplify's Rating
Why Onyx Bio is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consulting

Industrial & Manufacturing

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2024

Get referred to Onyx Bio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FY26 revenue rose to ₹6,946.94 lakh, up from ₹6,195.37 lakh.
  • Onyx Biotec reported no IPO-proceeds deviation on May 14, 2026, supporting governance.
  • January 2026 DRC Congo export approval expands its addressable market beyond India.

What critics are saying

  • FY26 ended with a ₹21.44 lakh loss as costs jumped to ₹7,033.57 lakh.
  • Managing Director Sanjay Jain and Whole Time Director Lakshya Jain resigned effective May 27, 2026.
  • Promoter sales and a September 2026 open offer signal control instability and takeover risk.

What makes Onyx Bio unique

  • Onyx Biotec runs WHO-GMP sterile injectables and dry-syrup manufacturing from Solan.
  • It bundles manufacturing, dossier filing, and end-to-end B2B supply for 100-plus pharma clients.
  • Its 2023 second unit targets EUGMP and Schedule M standards for export-grade production.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Company Equity

Professional Development Budget

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Onyx Bio right now.

Find jobs on Simplify and start your career today

We update Onyx Bio's jobs every few hours, so check again soon! Browse all jobs →